We are live on ! Find out more
PMC

PharMerica Corporation
PMC

Delisted

PMC was delisted on the 7th of December, 2017.

166 hedge funds and large institutions have $736M invested in PharMerica Corporation in 2016 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 59 increasing their positions, 55 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 55

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 20

3% less funds holding

Funds holding: 172166 (-6)

12% less capital invested

Capital invested by funds: $832M → $736M (-$95.9M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $3K

Holders
166
Holders Change
-6
Holders Change %
-3.49%
% of All Funds
4.15%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
19
Increased
59
Reduced
55
Closed
20
Calls
Puts
$3K
Net Calls
-$3K
Net Calls Change
+$3.14M
Name Holding Trade Value Shares
Change
Change in
Stake
NFG
151
Next Financial Group
Texas
$5K
LTFS
152
Ladenburg Thalmann Financial Services
Florida
$3K
MFW
153
Mosaic Family Wealth
Missouri
$3K
GAM
154
Gemmer Asset Management
California
$3K +$404 +16 +18%
IAS
155
INR Advisory Services
Pennsylvania
$2K
Fifth Third Bancorp
156
Fifth Third Bancorp
Ohio
$1K -$76 -3 -7%
QCG
157
Quadrant Capital Group
Ohio
$1K -$76 -3 -7%
First Manhattan
158
First Manhattan
New York
$1K
WA
159
WFG Advisors
Texas
$1K
TSW
160
Thompson Siegel & Walmsley
Virginia
$1K +$656 +26 New
Acadian Asset Management
161
Acadian Asset Management
Massachusetts
$1K +$1.34K +53 New
HCMT
162
Highland Capital Management (Texas)
Texas
-$5.35M -190,496 Closed
IHM
163
Iguana Healthcare Management
New York
-$4.21M -150,000 Closed
PCM
164
Pentwater Capital Management
Florida
-$2.54M -90,500 Closed
Macquarie Group
165
Macquarie Group
Australia
-$2.25M -80,000 Closed
GL
166
GLG LLC
New York
-$2.06M -73,195 Closed
MCC
167
Malaga Cove Capital
California
-$1.25M -45,229 Closed
EM
168
Endicott Management
New York
-$449K -16,000 Closed
AIM
169
Alambic Investment Management
California
-$429K -15,300 Closed
UBS AM
170
UBS AM
Illinois
-$424K -15,098 Closed
SAM
171
Symphony Asset Management
California
-$374K -13,303 Closed
AP
172
AHL Partners
United Kingdom
-$342K -12,197 Closed
NI
173
Numeric Investors
Massachusetts
-$320K -11,400 Closed
M&T Bank
174
M&T Bank
New York
-$296K -10,568 Closed
ICOM
175
Investment Counselors of Maryland
Maryland
-$253K -8,998 Closed

PMC Hedge Fund Activity: Q4 2016 in Review

166 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in PharMerica Corporation (PMC) for Q4 2016, worth a combined $736M — down 12% from $832M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of PMC and 19 opened new positions — a net loss of 1 holder — while 55 trimmed existing stakes and 59 added.

The largest buyer was Boston Partners, adding an estimated $23.1M. The largest seller was Balyasny Asset Management, cutting an estimated $16.2M.

  • 166 institutional investors held PharMerica Corporation (PMC) as of Q4 2016, down from 172 in Q3 2016.
  • Funds reported $736M of PharMerica Corporation stock for Q4 2016, down 12% quarter-over-quarter.
  • 19 funds opened new PharMerica Corporation positions in Q4 2016 and 20 closed out, a net change of -1 holder.
  • The largest PharMerica Corporation buyer in Q4 2016 was Boston Partners, an estimated $23.1M added.
  • The largest PharMerica Corporation seller in Q4 2016 was Balyasny Asset Management, an estimated $16.2M sold.

Based on aggregated 13F filings for Q4 2016.